Your browser doesn't support javascript.
Serial Assessment of Myocardial Injury Markers in Mechanically Ventilated Patients With SARS-CoV-2 (from the Prospective MaastrICCht Cohort).
Ghossein, Mohammed A; Driessen, Rob G H; van Rosmalen, Frank; Sels, Jan-Willem E M; Delnoij, Thijs; Geyik, Zafer; Mingels, Alma M A; van Stipdonk, Antonius M W; Prinzen, Frits W; Ghossein-Doha, Chahinda; van Kuijk, Sander M J; van der Horst, Iwan C C; Vernooy, Kevin; van Bussel, Bas C T.
  • Ghossein MA; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
  • Driessen RGH; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands; Department of Cardiology, Maastricht University Medical Centre+, Maastricht, the Netherlands; Department of Intensive Care Medicine, Maastricht University Medical Centre+, Maastricht, the Nether
  • van Rosmalen F; Department of Intensive Care Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • Sels JEM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands; Department of Cardiology, Maastricht University Medical Centre+, Maastricht, the Netherlands; Department of Intensive Care Medicine, Maastricht University Medical Centre+, Maastricht, the Nether
  • Delnoij T; Department of Cardiology, Maastricht University Medical Centre+, Maastricht, the Netherlands; Department of Intensive Care Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • Geyik Z; Department of Cardiology, Maastricht University Medical Centre+, Maastricht, the Netherlands; Department of Intensive Care Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • Mingels AMA; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands; Department of Clinical Chemistry, Central Diagnostic Laboratory, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • van Stipdonk AMW; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands; Department of Cardiology, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • Prinzen FW; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
  • Ghossein-Doha C; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands; Department of Cardiology, Maastricht University Medical Centre+, Maastricht, the Netherlands; Department of Intensive Care Medicine, Maastricht University Medical Centre+, Maastricht, the Nether
  • van Kuijk SMJ; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • van der Horst ICC; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands; Department of Intensive Care Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • Vernooy K; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands; Department of Cardiology, Maastricht University Medical Centre+, Maastricht, the Netherlands; Department of Cardiology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • van Bussel BCT; Department of Intensive Care Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands.
Am J Cardiol ; 170: 118-127, 2022 05 01.
Article in English | MEDLINE | ID: covidwho-1783146
ABSTRACT
Myocardial injury in COVID-19 is associated with in-hospital mortality. However, the development of myocardial injury over time and whether myocardial injury in patients with COVID-19 at the intensive care unit is associated with outcome is unclear. This study prospectively investigates myocardial injury with serial measurements over the full course of intensive care unit admission in mechanically ventilated patients with COVID-19. As part of the prospective Maastricht Intensive Care COVID cohort, predefined myocardial injury markers, including high-sensitivity cardiac troponin T (hs-cTnT), N-terminal pro-B-type natriuretic peptide (NT-proBNP), and electrocardiographic characteristics were serially collected in mechanically ventilated patients with COVID-19. Linear mixed-effects regression was used to compare survivors with nonsurvivors, adjusting for gender, age, APACHE-II score, daily creatinine concentration, hypertension, diabetes mellitus, and obesity. In 90 patients, 57 (63%) were survivors and 33 (37%) nonsurvivors, and a total of 628 serial electrocardiograms, 1,565 hs-cTnT, and 1,559 NT-proBNP concentrations were assessed. Log-hs-cTnT was lower in survivors compared with nonsurvivors at day 1 (ß -0.93 [-1.37; -0.49], p <0.001) and did not change over time. Log-NT-proBNP did not differ at day 1 between both groups but decreased over time in the survivor group (ß -0.08 [-0.11; -0.04] p <0.001) compared with nonsurvivors. Many electrocardiographic abnormalities were present in the whole population, without significant differences between both groups. In conclusion, baseline hs-cTnT and change in NT-proBNP were strongly associated with mortality. Two-thirds of patients with COVID-19 showed electrocardiographic abnormalities. Our serial assessment suggests that myocardial injury is common in mechanically ventilated patients with COVID-19 and is associated with outcome.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Am J Cardiol Year: 2022 Document Type: Article Affiliation country: J.amjcard.2022.01.030

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Am J Cardiol Year: 2022 Document Type: Article Affiliation country: J.amjcard.2022.01.030